Abstract:Human papillomaviruses (HPVs) have evolved over millions of years to propagate themselves in a range of different animal species including humans. Viruses that have co-evolved slowly in this way typically cause chronic inapparent infections, with virion production in the absence of apparent disease. This is the case for many Beta and Gamma HPV types. The Alpha papillomavirus types have however evolved immunoevasion strategies that allow them to cause persistent visible papillomas. These viruses activate the cell cycle as the infected epithelial cell differentiates in order to create a replication competent environment that allows viral genome amplification and packaging into infectious particles. This is mediated by the viral E6, E7, and E5 proteins. High-risk E6 and E7 proteins differ from their low-risk counterparts however in being able to drive cell cycle entry in the upper epithelial layers and also to stimulate cell proliferation in the basal and parabasal layers. Deregulated expression of these cell cycle regulators underlies neoplasia and the eventual progression to cancer in individuals who cannot resolve high-risk HPV infection. Most work to date has focused on the study of high-risk HPV types such as HPV 16 and 18, which has led to an understanding of the molecular pathways subverted by these viruses. Such approaches will lead to the development of better strategies for disease treatment, including targeted antivirals and immunotherapeutics. Priorities are now focused toward understanding HPV neoplasias at sites other than the cervix (e.g. tonsils, other transformation zones) and toward understanding the mechanisms by which low-risk HPV types can sometimes give rise to papillomatosis and under certain situations even cancers.

Reseach Progress on Human Papillomavirus and Its Related Carcinogenesis

Human papillomavirus infection and host innate immune responses

Engagement of Programmed Cell Death 1 and Its Ligands in Human Papillomaviurs Related Diseases

Advances on Autophagy and Human Papillomavirus

Human Papillomavirus Infection and Host Immune Response

Advances of Research on the Carcinogenesis of Human Papillomavirus

Mechanism of Human Papillomavirus Infection on the Dendritic Cells

Development of Human Papillomavirus Detection

Ubiquitination in Host Immune Response to Human Papillomavirus Infection

Progress in Human Papillomavirus-Induced Oncogenesis

[Research on the Oncogenesis of Cervical Epithelial Cells Co-Induced by Human Papillomavirus and Human Cytomegalovirus].

Human papillomavirus molecular biology and disease association

Human Papillomavirus Associated Cervical Lesion: Pathogenesis and Therapeutic Interventions

Unveiling the multifaceted realm of human papillomavirus: a comprehensive exploration of biology, interactions, and advances in cancer management

Structural biology of the human papillomavirus

Research progress and preventive strategy of HPV and cervical cancer and other related cancers

Natural History of Human Papilloma Virus Infection of the Cervix

Human Papillomavirus: It’s Characteristics, Pathogenesis, Transmission, Immunity, and it’s Role in Cervical Cancer: A Mini Review

Papillomaviruses and cancer: from basic studies to clinical application

Papel del virus del papiloma humano en el desarrollo del cáncer del cuello uterino.

The Mechanisms Used by Human Papillomavirus to Escape the Host Immune Response